<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://dirros.openscience.si/IzpisGradiva.php?id=28623"><dc:title>The association between adult IgA vasculitis and cancer</dc:title><dc:creator>Hočevar,	Alojzija	(Avtor)
	</dc:creator><dc:creator>Jurčić,	Vesna	(Avtor)
	</dc:creator><dc:creator>Rotar,	Žiga	(Avtor)
	</dc:creator><dc:subject>adult IgA vasculitis</dc:subject><dc:subject>cancer</dc:subject><dc:subject>risk factor</dc:subject><dc:subject>temporal relation</dc:subject><dc:subject>urogenital cancers</dc:subject><dc:description>Objectives: Cancer has been reported as a potential trigger for IgA vasculitis (IgAV) in adults; however, data on this topic are scarce. The aim of our study was to examine the frequency and location of cancer in adults with IgAV. Methods: We included 295 IgAV patients diagnosed between January 2010 and June 2021 and followed at our secondary/tertiary rheumatology centre. Cancer episodes were recorded and classified into three groups according to their temporal relation to IgAV: (1) cancer diagnosed prior to IgAV; (2) cancer diagnosed concurrently with IgAV; and (3) cancer diagnosed during IgAV follow-up. The term IgAV associated with cancer (IgAV-CA) was used for IgAV cases presenting while cancer was active or diagnosed within a three-year period before or after the IgAV diagnosis. Results: Forty-seven IgAV patients (15.9%) developed a total of 56 different cancers. Of these, 43 cancers (76.8%) preceded the IgAV diagnosis, 3 cancers (5.3%) were diagnosed concurrently with IgAV, and 10 cancers (17.9%) were diagnosed during the IgAV follow-up. Twenty-two IgAV patients (7.5%) who developed a total of 24 cancers (42.9%) could be classified as IgAV-CA cases. The three most frequently diagnosed cancers in the IgAV-CA group were prostatic, renal and bladder cancer, together accounting for 50% of cancers. Age and smoking were associated with concurrent cancers, and arthritis represented a risk factor for cancer development during IgAV follow-up. Conclusion: IgAV cases associated with cancer represent 7% of adult IgAV cases. In elderly patients, careful examination of the urogenital tract is warranted when cancer is suspected.</dc:description><dc:date>2025</dc:date><dc:date>2026-03-26 09:47:19</dc:date><dc:type>Neznano</dc:type><dc:identifier>28623</dc:identifier><dc:language>sl</dc:language></rdf:Description></rdf:RDF>
